Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer
This study aimed to investigate the efficacy of additional surgical resection (ASR) after endoscopic submucosal dissection (ESD) for superficial esophageal cancer (SEC). Clinicopathological features and prognoses were analyzed in esophageal cancer (EC) cases with the indication for additional treatm...
Gespeichert in:
| Veröffentlicht in: | Anticancer research 2017-09, Vol.37 (9), p.5301-5307 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5307 |
|---|---|
| container_issue | 9 |
| container_start_page | 5301 |
| container_title | Anticancer research |
| container_volume | 37 |
| creator | Kudou, Michihiro Shiozaki, Atsushi Fujiwara, Hitoshi Konishi, Hirotaka Shoda, Katsutoshi Arita, Tomohiro Kosuga, Toshiyuki Morimura, Ryo Murayama, Yasutoshi Kuriu, Yoshiaki Ikoma, Hisashi Kubota, Takeshi Nakanishi, Masayoshi Okamoto, Kazuma Dohi, Osamu Konishi, Hideyuki Naito, Yuji Otsuji, Eigo |
| description | This study aimed to investigate the efficacy of additional surgical resection (ASR) after endoscopic submucosal dissection (ESD) for superficial esophageal cancer (SEC).
Clinicopathological features and prognoses were analyzed in esophageal cancer (EC) cases with the indication for additional treatments (AT) after ESD (37 cases) and in cases that underwent primary resection (13 cases).
Sixteen out of 37 cases underwent ASR. The remaining 21 cases underwent other treatments or observation. Although all ASR cases are alive without recurrence, recurrence developed in 2 non-ASR cases. Residual tumors were detected in 2 ASR cases. All 4 cases were T1b and positive for lymph vessel invasion (ly+). No significant difference was observed in surgical outcomes between ASR and primary surgical resection (PSR) cases.
AT need to be considered for T1b and ly+ cases, and ASR is one of the effective AT. The safety of ASR was similar to PSR for SEC. |
| doi_str_mv | 10.21873/anticanres.11956 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1935814152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1935814152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c296t-b07c93b6808af871b8b9d812cd42278ba630245793b7fe57fd8447c11056feb53</originalsourceid><addsrcrecordid>eNpFkMlOwzAURS0EoqXwAWxQlmxSPMTTsiphkCohMawjx7GLURoHO1n07zEdYPWe3j3vLg4A1wjOMRKc3KlucFp1wcQ5QpKyEzBFXKKcUwJPwRRiCnMOIZ2Aixi_IGRMCnIOJlgIDiUTUxBKa1OF3mbeZoumcYPznWqztzGs073NXk00-veYLexgQlZ2jY_a904npt6M2sdE3bt4xKwPKelNSL0uRWX0_adam7QuVadNuARnVrXRXB3mDHw8lO_Lp3z18vi8XKxyjSUb8hpyLUnNBBTKCo5qUctGIKybAmMuasUIxAXlieHWUG4bURRcIwQps6amZAZu97198N-jiUO1cVGbtlWd8WOskCRUoAJRnFC0R3XwMQZjqz64jQrbCsFqp7r6V13tVKefm0N90mCav4-jW_IDkTJ-GQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1935814152</pqid></control><display><type>article</type><title>Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kudou, Michihiro ; Shiozaki, Atsushi ; Fujiwara, Hitoshi ; Konishi, Hirotaka ; Shoda, Katsutoshi ; Arita, Tomohiro ; Kosuga, Toshiyuki ; Morimura, Ryo ; Murayama, Yasutoshi ; Kuriu, Yoshiaki ; Ikoma, Hisashi ; Kubota, Takeshi ; Nakanishi, Masayoshi ; Okamoto, Kazuma ; Dohi, Osamu ; Konishi, Hideyuki ; Naito, Yuji ; Otsuji, Eigo</creator><creatorcontrib>Kudou, Michihiro ; Shiozaki, Atsushi ; Fujiwara, Hitoshi ; Konishi, Hirotaka ; Shoda, Katsutoshi ; Arita, Tomohiro ; Kosuga, Toshiyuki ; Morimura, Ryo ; Murayama, Yasutoshi ; Kuriu, Yoshiaki ; Ikoma, Hisashi ; Kubota, Takeshi ; Nakanishi, Masayoshi ; Okamoto, Kazuma ; Dohi, Osamu ; Konishi, Hideyuki ; Naito, Yuji ; Otsuji, Eigo</creatorcontrib><description>This study aimed to investigate the efficacy of additional surgical resection (ASR) after endoscopic submucosal dissection (ESD) for superficial esophageal cancer (SEC).
Clinicopathological features and prognoses were analyzed in esophageal cancer (EC) cases with the indication for additional treatments (AT) after ESD (37 cases) and in cases that underwent primary resection (13 cases).
Sixteen out of 37 cases underwent ASR. The remaining 21 cases underwent other treatments or observation. Although all ASR cases are alive without recurrence, recurrence developed in 2 non-ASR cases. Residual tumors were detected in 2 ASR cases. All 4 cases were T1b and positive for lymph vessel invasion (ly+). No significant difference was observed in surgical outcomes between ASR and primary surgical resection (PSR) cases.
AT need to be considered for T1b and ly+ cases, and ASR is one of the effective AT. The safety of ASR was similar to PSR for SEC.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>DOI: 10.21873/anticanres.11956</identifier><identifier>PMID: 28870968</identifier><language>eng</language><publisher>Greece</publisher><subject>Aged ; Disease-Free Survival ; Endoscopic Mucosal Resection ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; Female ; Humans ; Male ; Middle Aged ; Survival Analysis ; Treatment Outcome</subject><ispartof>Anticancer research, 2017-09, Vol.37 (9), p.5301-5307</ispartof><rights>Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28870968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kudou, Michihiro</creatorcontrib><creatorcontrib>Shiozaki, Atsushi</creatorcontrib><creatorcontrib>Fujiwara, Hitoshi</creatorcontrib><creatorcontrib>Konishi, Hirotaka</creatorcontrib><creatorcontrib>Shoda, Katsutoshi</creatorcontrib><creatorcontrib>Arita, Tomohiro</creatorcontrib><creatorcontrib>Kosuga, Toshiyuki</creatorcontrib><creatorcontrib>Morimura, Ryo</creatorcontrib><creatorcontrib>Murayama, Yasutoshi</creatorcontrib><creatorcontrib>Kuriu, Yoshiaki</creatorcontrib><creatorcontrib>Ikoma, Hisashi</creatorcontrib><creatorcontrib>Kubota, Takeshi</creatorcontrib><creatorcontrib>Nakanishi, Masayoshi</creatorcontrib><creatorcontrib>Okamoto, Kazuma</creatorcontrib><creatorcontrib>Dohi, Osamu</creatorcontrib><creatorcontrib>Konishi, Hideyuki</creatorcontrib><creatorcontrib>Naito, Yuji</creatorcontrib><creatorcontrib>Otsuji, Eigo</creatorcontrib><title>Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>This study aimed to investigate the efficacy of additional surgical resection (ASR) after endoscopic submucosal dissection (ESD) for superficial esophageal cancer (SEC).
Clinicopathological features and prognoses were analyzed in esophageal cancer (EC) cases with the indication for additional treatments (AT) after ESD (37 cases) and in cases that underwent primary resection (13 cases).
Sixteen out of 37 cases underwent ASR. The remaining 21 cases underwent other treatments or observation. Although all ASR cases are alive without recurrence, recurrence developed in 2 non-ASR cases. Residual tumors were detected in 2 ASR cases. All 4 cases were T1b and positive for lymph vessel invasion (ly+). No significant difference was observed in surgical outcomes between ASR and primary surgical resection (PSR) cases.
AT need to be considered for T1b and ly+ cases, and ASR is one of the effective AT. The safety of ASR was similar to PSR for SEC.</description><subject>Aged</subject><subject>Disease-Free Survival</subject><subject>Endoscopic Mucosal Resection</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMlOwzAURS0EoqXwAWxQlmxSPMTTsiphkCohMawjx7GLURoHO1n07zEdYPWe3j3vLg4A1wjOMRKc3KlucFp1wcQ5QpKyEzBFXKKcUwJPwRRiCnMOIZ2Aixi_IGRMCnIOJlgIDiUTUxBKa1OF3mbeZoumcYPznWqztzGs073NXk00-veYLexgQlZ2jY_a904npt6M2sdE3bt4xKwPKelNSL0uRWX0_adam7QuVadNuARnVrXRXB3mDHw8lO_Lp3z18vi8XKxyjSUb8hpyLUnNBBTKCo5qUctGIKybAmMuasUIxAXlieHWUG4bURRcIwQps6amZAZu97198N-jiUO1cVGbtlWd8WOskCRUoAJRnFC0R3XwMQZjqz64jQrbCsFqp7r6V13tVKefm0N90mCav4-jW_IDkTJ-GQ</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Kudou, Michihiro</creator><creator>Shiozaki, Atsushi</creator><creator>Fujiwara, Hitoshi</creator><creator>Konishi, Hirotaka</creator><creator>Shoda, Katsutoshi</creator><creator>Arita, Tomohiro</creator><creator>Kosuga, Toshiyuki</creator><creator>Morimura, Ryo</creator><creator>Murayama, Yasutoshi</creator><creator>Kuriu, Yoshiaki</creator><creator>Ikoma, Hisashi</creator><creator>Kubota, Takeshi</creator><creator>Nakanishi, Masayoshi</creator><creator>Okamoto, Kazuma</creator><creator>Dohi, Osamu</creator><creator>Konishi, Hideyuki</creator><creator>Naito, Yuji</creator><creator>Otsuji, Eigo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170901</creationdate><title>Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer</title><author>Kudou, Michihiro ; Shiozaki, Atsushi ; Fujiwara, Hitoshi ; Konishi, Hirotaka ; Shoda, Katsutoshi ; Arita, Tomohiro ; Kosuga, Toshiyuki ; Morimura, Ryo ; Murayama, Yasutoshi ; Kuriu, Yoshiaki ; Ikoma, Hisashi ; Kubota, Takeshi ; Nakanishi, Masayoshi ; Okamoto, Kazuma ; Dohi, Osamu ; Konishi, Hideyuki ; Naito, Yuji ; Otsuji, Eigo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c296t-b07c93b6808af871b8b9d812cd42278ba630245793b7fe57fd8447c11056feb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Disease-Free Survival</topic><topic>Endoscopic Mucosal Resection</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kudou, Michihiro</creatorcontrib><creatorcontrib>Shiozaki, Atsushi</creatorcontrib><creatorcontrib>Fujiwara, Hitoshi</creatorcontrib><creatorcontrib>Konishi, Hirotaka</creatorcontrib><creatorcontrib>Shoda, Katsutoshi</creatorcontrib><creatorcontrib>Arita, Tomohiro</creatorcontrib><creatorcontrib>Kosuga, Toshiyuki</creatorcontrib><creatorcontrib>Morimura, Ryo</creatorcontrib><creatorcontrib>Murayama, Yasutoshi</creatorcontrib><creatorcontrib>Kuriu, Yoshiaki</creatorcontrib><creatorcontrib>Ikoma, Hisashi</creatorcontrib><creatorcontrib>Kubota, Takeshi</creatorcontrib><creatorcontrib>Nakanishi, Masayoshi</creatorcontrib><creatorcontrib>Okamoto, Kazuma</creatorcontrib><creatorcontrib>Dohi, Osamu</creatorcontrib><creatorcontrib>Konishi, Hideyuki</creatorcontrib><creatorcontrib>Naito, Yuji</creatorcontrib><creatorcontrib>Otsuji, Eigo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kudou, Michihiro</au><au>Shiozaki, Atsushi</au><au>Fujiwara, Hitoshi</au><au>Konishi, Hirotaka</au><au>Shoda, Katsutoshi</au><au>Arita, Tomohiro</au><au>Kosuga, Toshiyuki</au><au>Morimura, Ryo</au><au>Murayama, Yasutoshi</au><au>Kuriu, Yoshiaki</au><au>Ikoma, Hisashi</au><au>Kubota, Takeshi</au><au>Nakanishi, Masayoshi</au><au>Okamoto, Kazuma</au><au>Dohi, Osamu</au><au>Konishi, Hideyuki</au><au>Naito, Yuji</au><au>Otsuji, Eigo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2017-09-01</date><risdate>2017</risdate><volume>37</volume><issue>9</issue><spage>5301</spage><epage>5307</epage><pages>5301-5307</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>This study aimed to investigate the efficacy of additional surgical resection (ASR) after endoscopic submucosal dissection (ESD) for superficial esophageal cancer (SEC).
Clinicopathological features and prognoses were analyzed in esophageal cancer (EC) cases with the indication for additional treatments (AT) after ESD (37 cases) and in cases that underwent primary resection (13 cases).
Sixteen out of 37 cases underwent ASR. The remaining 21 cases underwent other treatments or observation. Although all ASR cases are alive without recurrence, recurrence developed in 2 non-ASR cases. Residual tumors were detected in 2 ASR cases. All 4 cases were T1b and positive for lymph vessel invasion (ly+). No significant difference was observed in surgical outcomes between ASR and primary surgical resection (PSR) cases.
AT need to be considered for T1b and ly+ cases, and ASR is one of the effective AT. The safety of ASR was similar to PSR for SEC.</abstract><cop>Greece</cop><pmid>28870968</pmid><doi>10.21873/anticanres.11956</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0250-7005 |
| ispartof | Anticancer research, 2017-09, Vol.37 (9), p.5301-5307 |
| issn | 0250-7005 1791-7530 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1935814152 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Aged Disease-Free Survival Endoscopic Mucosal Resection Esophageal Neoplasms - pathology Esophageal Neoplasms - surgery Female Humans Male Middle Aged Survival Analysis Treatment Outcome |
| title | Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T04%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Additional%20Surgical%20Resection%20After%20Endoscopic%20Submucosal%20Dissection%20for%20Superficial%20Esophageal%20Cancer&rft.jtitle=Anticancer%20research&rft.au=Kudou,%20Michihiro&rft.date=2017-09-01&rft.volume=37&rft.issue=9&rft.spage=5301&rft.epage=5307&rft.pages=5301-5307&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/10.21873/anticanres.11956&rft_dat=%3Cproquest_cross%3E1935814152%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1935814152&rft_id=info:pmid/28870968&rfr_iscdi=true |